Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
2.140
-0.060 (-2.73%)
Nov 21, 2024, 12:26 PM EST - Market open

Lexaria Bioscience Revenue

Lexaria Bioscience had revenue of $84.00K in the quarter ending May 31, 2024, with 8.10% growth. This brings the company's revenue in the last twelve months to $411.02K, up 34.05% year-over-year. In the fiscal year ending August 31, 2023, Lexaria Bioscience had annual revenue of $226.21K, down -11.43%.

Revenue (ttm)
$411.02K
Revenue Growth
+34.05%
P/S Ratio
56.11
Revenue / Employee
$82,204
Employees
5
Market Cap
37.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Aug 31, 2023226.21K-29.19K-11.43%
Aug 31, 2022255.40K-467.34K-64.66%
Aug 31, 2021722.74K407.95K129.59%
Aug 31, 2020314.79K92.18K41.41%
Aug 31, 2019222.61K-210.68K-48.62%
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Aug 31, 2015 Pro Pro Pro
Aug 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.